A growing number of doctors are advocating to rename low-grade prostate cancer to reduce unnecessary aggressive treatments that can lead to debilitating side effects. About one-quarter of men diagnosed with prostate cancer have the lowest-risk form, yet studies show 40% opt for surgery or radiation despite recommendations for active surveillance.

The push comes amid mounting evidence that careful monitoring is effective in managing low-grade cases. A U.K. study of 1,600 men found similar 15-year mortality rates between those who chose surgery, radiation or surveillance. Some doctors oppose the change, warning it could reduce patient compliance with follow-up care.

[ Read more of this story ]( https://science.slashdot.org/story/25/01/27/1515239/the-cancer-that-doctors-dont-want-to-call-cancer?utm_source=atom1.0moreanon&utm_medium=feed ) at Slashdot.